21:40 , Aug 20, 2018 |  BC Extra  |  Company News

Management tracks: Athenex, Intra-Cellular

Cancer company Athenex Inc. (NASDAQ:ATNX) said Director of Corporate Development and Investor Relations Randoll Sze will become CFO. Neurology play Intra-Cellular Therapies Inc. (NASDAQ:ITCI) hired Suresh Durgam as SVP of late-stage clinical development and medical affairs....
20:15 , Jun 15, 2018 |  BC Week In Review  |  Financial News

Aivita raises $15M series B, considers Korean clinical trial for cancer therapy

Cellular therapy company Aivita Biomedical Inc. (Irvine, Calif.) raised $15 million on June 11 in a series B round led by sole South Korean investor SFC Co. Ltd. (KOSDAQ:112240). The round gives it a cash...
07:00 , Jun 20, 2016 |  BC Week In Review  |  Financial News

AiVita Biomedical completes venture financing

AiVita Biomedical Inc., Irvine, Calif.   Business: Gene/Cell therapy, Dermatology, Cancer   Date completed: 2016-06-10   Type: Venture financing   Raised: $2 million   Investor: California Technology Ventures   ...
07:00 , Jun 6, 2016 |  BC Week In Review  |  Company News

Caladrius Biosciences, AiVita Biomedical deal

Caladrius granted AiVita exclusive, worldwide rights to tumor cell/dendritic cell technology to treat ovarian cancer. Caladrius is eligible for undisclosed development milestones and royalties. AiVita plans to begin a Phase II trial this year. AiVita...